59 articles, transcripts, and reports
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment registering strong sales…
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations Robert B. Ford — Chairman and Chief Executive…
Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for the first quarter were $2.4…
Abbott Laboratories (NYSE: ABT) Q1 2022 Earnings Conference
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing & Acquisitions Robert B. Ford — Chairman…
Abbott Laboratories (NYSE: ABT) Q4 2021 Earnings Conference
Abbott Laboratories (NYSE: ABT) Q4 2021 Earnings Conference
Abbott (NYSE: ABT) today reported its third quarter financial results for the period ended September 30, 2021. GAAP net earnings for the third quarter was…
Abbott Laboratories (NYSE: ABT) Q3 2021 earnings call dated Oct. 20, 2021 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing & Acquisitions Robert B. Ford — President…
The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective procedures resuming. Abbott Laboratories (NYSE:…
